Suppr超能文献

高岭土激活血栓弹力描记术与一组特定试剂的诊断性能和治疗后果。

Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents.

机构信息

Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark.

出版信息

Anesthesiology. 2011 Aug;115(2):294-302. doi: 10.1097/ALN.0b013e318220755c.

Abstract

BACKGROUND

Thromboelastography/metry (TEG®; Haemoscope, Niles, IL/ROTEM®; Tem International GmbH, Munich, Germany) is increasingly used to guide transfusion therapy. This study investigated the diagnostic performance and therapeutic consequence of using kaolin-activated whole blood compared with a panel of specific TEM®-reagents to distinguish: dilutional coagulopathy, thrombocytopenia, hyperfibrinolysis, and heparinization.

METHODS

Blood was drawn from 11 healthy volunteers. Dilutional coagulopathy was generated by 50% dilution with hydroxyethyl starch 130/0.4 whereas thrombocytopenia (mean platelet count 20 ×10⁹/l) was induced using a validated model. Hyperfibrinolysis and heparin contamination were generated by tissue plasminogen activator 2 nM and unfractionated heparin 0.1U/ml, respectively. Coagulation tests were run on ROTEM® delta.

RESULTS

Kaolin-activated whole blood showed no differences between dilutional coagulopathy and thrombocytopenia (mean clotting time 450 s vs. 516 s, α-angle 47.1° vs. 41.5°, maximum clot firmness 35.0 mm vs. 34.2 mm, all P values ≥0.14). Hyperfibrinolysis specifically disclosed an increased maximum lysis (median: 100%, all P values less than 0.001), and heparin induced a distinctly prolonged clotting time (2283 s, all P values less than 0.02). The coagulopathies were readily distinguishable using a panel of TEM-reagents. In particular, dilutional coagulopathy was separated from thrombocytopenia using FIBTEM (maximum clot firmness 1.9 mm vs. 11.2 mm, P < 0.001). The run time of analysis to achieve diagnostic data was shorter applying a panel of TEM-reagents. A transfusion algorithm based on kaolin suggested platelets in case of dilutional coagulopathy, whereas an algorithm applying TEM-reagents suggested fibrinogen.

CONCLUSION

Monoanalysis with kaolin was unable to distinguish coagulopathies caused by dilution from that of thrombocytopenia. Algorithms based on the use of kaolin may lead to unnecessary transfusion with platelets, whereas the application of TEM-reagents may result in goal-directed fibrinogen substitution.

摘要

背景

血栓弹力描记术/测量法(TEG®;Haemoscope,Niles,IL/ROTEM®;Tem International GmbH,慕尼黑,德国)越来越多地用于指导输血治疗。本研究旨在使用高岭土激活全血与特定 TEM®试剂组合来区分稀释性凝血障碍、血小板减少症、纤维蛋白溶解亢进和肝素化,并评估其诊断性能和治疗效果。

方法

从 11 名健康志愿者中抽取血液。通过 50%羟乙基淀粉 130/0.4 稀释生成稀释性凝血障碍,使用经验证的模型诱导血小板减少症(平均血小板计数 20×10⁹/L)。使用组织型纤溶酶原激活物 2nM 和未分级肝素 0.1U/ml 分别生成纤维蛋白溶解亢进和肝素污染。凝血试验在 ROTEM® delta 上进行。

结果

高岭土激活全血在稀释性凝血障碍和血小板减少症之间无差异(凝血时间分别为 450s 和 516s,α 角分别为 47.1°和 41.5°,最大凝块硬度分别为 35.0mm 和 34.2mm,所有 P 值均≥0.14)。纤维蛋白溶解亢进特异地显示出增加的最大溶解(中位数:100%,所有 P 值均小于 0.001),肝素引起明显延长的凝血时间(2283s,所有 P 值均小于 0.02)。使用 TEM 试剂组合可轻松区分凝血障碍。特别是,FIBTEM 将稀释性凝血障碍与血小板减少症区分开来(最大凝块硬度分别为 1.9mm 和 11.2mm,P<0.001)。应用 TEM 试剂组合分析的运行时间更短,可更快获得诊断数据。基于高岭土的输血算法建议在发生稀释性凝血障碍时输注血小板,而基于 TEM 试剂的算法则建议输注纤维蛋白原。

结论

单独使用高岭土无法区分稀释性凝血障碍和血小板减少症引起的凝血障碍。基于高岭土使用的算法可能导致不必要的血小板输注,而应用 TEM 试剂可能导致有针对性的纤维蛋白原替代。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验